Yüklüyor......
Pancreatic Ductal Adenocarcinoma: MicroRNAs Affecting Tumor Growth and Metastasis in Preclinical In Vivo Models
Patients with pancreatic ductal adenocarcinoma have a dismall prognosis because at the time of diagnosis, in the vast majority of patients the tumor has already disseminated to distant organs and the therapeutic benefit of approved agents such as gemcitabine is limited. Therefore, the identification...
Kaydedildi:
| Yayımlandı: | Cancer Genomics Proteomics |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
International Institute of Anticancer Research
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6885366/ https://ncbi.nlm.nih.gov/pubmed/31659100 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/cgp.20149 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|